Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Bronx › NPI 1659446680
Clinic

Montefiore Medical Center

Montefiore Medical Center was paid $8.13M by Medicaid between Jan 2018 and Mar 2023, across 252 billing codes. Its largest line is 90832, psychotherapy session, about 30 minutes — 7.9% of everything it billed.

33Billing provider infoMONTEFIORE MEDICAL CENTER
BRONX, NY 10467
33aNPI1659446680assigned 11/22/2006
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$8.13M
24GClaims248,104
24DCodes billed252
24AFirst – last monthJan 2018 – Mar 2023
Compared with peers

Next to other Federally Qualified Health Center (FQHC) providers in New York

Rank by total paid#39 of 158
Median peer was paid$1.73M
This provider vs. median4.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201826$0.00
201930,974$1.44M
202058,184$1.67M
202171,827$2.02M
202265,494$2.16M
202321,599$834K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
90832 Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient 7.9% 4,973 3,356 $638K
80053 Comprehensive metabolic panel 7.0% 13,031 12,135 $569K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 4.5% 7,311 6,044 $369K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 4.3% 3,378 2,903 $348K
96375 Therapeutic injection; each additional sequential IV push 3.6% 1,075 867 $295K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 3.3% 159 117 $268K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 3.1% 284 260 $252K
36415 Collection of venous blood by venipuncture 3.0% 4,139 3,899 $241K
96361 Intravenous infusion, hydration; each additional hour 2.9% 921 852 $237K
81001 2.9% 3,912 3,732 $237K
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) 2.8% 1,552 1,363 $227K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2.6% 3,734 3,532 $210K
240 more codes
88305 Level IV - Surgical pathology, gross and microscopic examination 2.5% 1,110 $204K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 2.4% 1,393 $195K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 2.3% 4,702 $190K
99214 Doctor's office visit, returning patient (more involved) 2.2% 1,386 $181K
86850 2.2% 2,024 $181K
90834 Psychotherapy session, about 45 minutes 2.0% 1,024 $161K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.7% 1,070 $140K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.6% 1,659 $131K
87806 1.6% 2,284 $130K
87631 1.5% 1,362 $121K
86480 1.5% 1,087 $119K
80061 Lipid panel 1.3% 9,459 $107K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.3% 1,588 $105K
81003 1.2% 1,772 $99K
80048 Basic metabolic panel (calcium, ionized) 1.2% 3,318 $95K
99283 Emergency room visit (moderate) 1.0% 1,846 $84K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 1,823 $78K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 537 $65K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,127 $64K
77063 Screening digital breast tomosynthesis, bilateral <1% 494 $61K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 18,566 $58K
87081 <1% 1,165 $55K
86900 <1% 2,032 $51K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,237 $50K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 426 $49K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 414 $47K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 264 $47K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 341 $45K
86769 <1% 741 $42K
71046 Radiologic examination, chest; 2 views <1% 1,432 $41K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 251 $39K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 160 $38K
86901 <1% 2,032 $38K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 4,223 $37K
99284 Emergency room visit (serious) <1% 1,101 $37K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 736 $35K
92551 <1% 669 $35K
82948 <1% 843 $33K
86780 <1% 2,926 $32K
87481 <1% 199 $30K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,702 $30K
80076 <1% 1,783 $29K
82728 <1% 2,653 $29K
90686 <1% 1,965 $25K
90791 Psychiatric diagnostic evaluation <1% 121 $24K
83655 <1% 1,128 $23K
82784 <1% 596 $23K
87486 <1% 78 $21K
87070 <1% 376 $21K
83021 <1% 547 $21K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 26 $20K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 811 $20K
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit <1% 224 $20K
83036 Hemoglobin; glycosylated (A1C) <1% 8,898 $19K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 249 $15K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 476 $15K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 134 $14K
0002A <1% 362 $14K
0001A <1% 418 $14K
84439 <1% 3,473 $14K
90836 <1% 82 $14K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 205 $14K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 139 $13K
84702 <1% 1,848 $13K
82607 <1% 2,188 $13K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 88 $13K
85610 <1% 2,140 $11K
87077 <1% 694 $11K
86803 <1% 2,331 $11K
99285 Emergency room visit (most serious) <1% 674 $11K
84443 Thyroid stimulating hormone (TSH) <1% 6,934 $11K
86359 <1% 87 $11K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 247 $10K
99215 Doctor's office visit, returning patient (complex) <1% 55 $10K
96127 <1% 1,372 $10K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 56 $9K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 265 $9K
J2704 Injection, propofol, 10 mg <1% 1,163 $9K
87490 <1% 1,587 $9K
83735 <1% 2,185 $9K
82330 <1% 1,258 $9K
84466 <1% 2,362 $8K
G0475 Hiv antigen/antibody, combination assay, screening <1% 1,447 $8K
90670 <1% 335 $8K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,183 $7K
83615 <1% 842 $7K
86140 <1% 972 $7K
83540 <1% 2,447 $6K
97010 <1% 106 $6K
87205 <1% 377 $6K
90651 <1% 214 $6K
0003A <1% 154 $6K
73630 <1% 48 $6K
J7050 Infusion, normal saline solution, 250 cc <1% 1,681 $6K
87581 <1% 78 $5K
92557 <1% 44 $5K
82043 <1% 1,661 $5K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 1,184 $4K
84100 <1% 1,315 $4K
86706 <1% 1,089 $4K
82565 <1% 227 $4K
82550 <1% 1,338 $4K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 3,957 $4K
70450 Computed tomography, head or brain; without contrast material <1% 46 $4K
90734 <1% 203 $3K
85046 <1% 281 $3K
82785 <1% 101 $3K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 25 $3K
86704 <1% 415 $3K
77065 Tomosynthesis, mammo <1% 14 $3K
84484 <1% 1,139 $2K
83690 <1% 1,343 $2K
J3490 Unclassified drugs <1% 1,548 $2K
82570 <1% 2,098 $2K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 708 $2K
82746 <1% 859 $2K
83880 <1% 277 $2K
76830 Ultrasound, transvaginal <1% 40 $2K
84153 <1% 315 $2K
84550 <1% 816 $2K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 492 $2K
90853 Group psychotherapy (other than of a multiple-family group) <1% 33 $2K
99173 <1% 26 $2K
86592 <1% 29 $2K
83605 <1% 1,243 $2K
87340 <1% 1,820 $2K
J7030 Infusion, normal saline solution , 1000 cc <1% 1,262 $2K
90715 <1% 219 $2K
82375 <1% 1,243 $2K
83970 <1% 182 $2K
83001 <1% 212 $2K
85730 <1% 1,787 $2K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 15 $2K
71045 Radiologic examination, chest; single view <1% 30 $2K
76770 <1% 29 $1K
95117 <1% 65 $1K
86696 <1% 13 $1K
0124A <1% 94 $1K
84520 <1% 189 $1K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 65 $1K
86735 <1% 459 $1K
93970 <1% 25 $1K
84703 <1% 63 $1K
H2010 Comprehensive medication services, per 15 minutes <1% 19 $1K
86762 <1% 648 $1K
82947 <1% 1,564 $1K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 1,375 $1K
90680 <1% 146 $1K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 56 $1K
85044 <1% 551 $1K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 147 $1K
73610 <1% 14 $1K
82150 <1% 260 $1K
90633 <1% 136 $971.15
92083 <1% 12 $965.30
J7120 Ringers lactate infusion, up to 1000 cc <1% 923 $913.86
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 830 $894.83
86360 <1% 87 $842.30
84295 <1% 1,407 $829.69
0011A <1% 20 $800.00
0012A <1% 20 $795.00
73560 <1% 13 $756.39
82800 <1% 1,239 $747.93
84403 <1% 203 $740.20
85652 <1% 929 $719.50
84146 <1% 109 $699.33
86038 <1% 310 $680.95
86200 <1% 13 $672.83
92567 <1% 51 $642.53
99385 <1% 16 $583.54
83050 <1% 1,243 $574.45
86765 <1% 694 $565.31
87088 <1% 788 $448.25
82310 <1% 52 $446.12
84132 <1% 1,156 $440.24
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 1,371 $439.59
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient <1% 12 $377.35
86787 <1% 592 $376.17
86003 <1% 163 $364.96
80197 <1% 64 $358.97
90696 <1% 16 $346.45
90698 <1% 27 $329.77
81025 <1% 12 $313.22
82465 <1% 88 $306.76
85651 <1% 197 $284.01
90723 <1% 25 $279.64
90750 <1% 12 $275.91
90710 <1% 67 $254.24
86708 <1% 53 $245.69
90648 <1% 13 $236.69
87186 <1% 337 $235.88
84156 <1% 594 $233.82
76642 <1% 18 $195.04
84436 <1% 27 $194.00
84155 <1% 86 $161.99
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 834 $154.37
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 576 $145.92
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 250 $138.60
82977 <1% 30 $134.00
87536 <1% 68 $119.42
H0049 Alcohol and/or drug screening <1% 188 $114.25
J8540 Dexamethasone, oral, 0.25 mg <1% 15 $109.56
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 882 $108.92
83520 <1% 14 $89.15
87563 <1% 38 $86.55
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 32 $79.42
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 319 $78.15
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,193 $55.79
87147 <1% 14 $55.00
84402 <1% 77 $35.98
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 1,081 $33.62
86161 <1% 12 $26.48
90697 <1% 13 $17.85
86225 <1% 27 $15.09
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 12 $11.97
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 583 $3.44
91312 <1% 79 $1.08
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 60 $0.74
91313 <1% 13 $0.13
S0020 Injection, bupivicaine hydrochloride, 30 ml 0% 70 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 0% 71 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 0% 48 $0.00
86376 0% 25 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 128 $0.00
84480 0% 26 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 0% 18 $0.00
86141 0% 15 $0.00
83002 0% 39 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 0% 45 $0.00
85362 0% 12 $0.00
86431 0% 105 $0.00
83516 0% 64 $0.00
81513 0% 198 $0.00
S0028 Injection, famotidine, 20 mg 0% 50 $0.00
86618 0% 12 $0.00
90472 Immunization administration, each additional vaccine (list separately) 0% 102 $0.00
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 0% 13 $0.00
99051 0% 26 $0.00
76857 0% 15 $0.00
90662 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPERLMAN, JOEL (CHIEF FINANCIAL OFFICER)
Parent organizationMONTEFIORE MEDICAL CENTER